ReviewFrontiers in immunology2022

Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma.

Lidawani Lambuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.